Filing Flows

Filing Flows › Precision Biosciences (DTIL) › Next earnings date

Precision Biosciences (DTIL) earnings: beat the estimate

Precision Biosciences (DTIL) reported on Nov 3, 2026 and beat the EPS estimate: −$0.28 against −$0.89 (+68.5%). It beat the EPS estimate in 80% of the quarters on record.

Last result+68.5% vs estimate
Beat rate80%

The last report

Precision Biosciences reported revenue of $10.8M for the third quarter fiscal 2026 (374× Y/Y), net loss $18.4M. How it makes money → · Every quarter →

Precision Biosciences: EPS against the estimate, last 5 reportsPrecision Biosciences: EPS against the estimate, last 5 reportsEstimateReported−$2.21−$1.84Nov 25−$0.64$1.01Mar 26−$0.81−$0.75May 26−$0.69−$1.26Aug 26−$0.89−$0.28Nov 26
Latest (Nov 26): Estimate −$0.89, Reported −$0.28.

Precision Biosciences' latest quarter

Precision Biosciences, Q3 FY26: revenue $10.8M (374× year over year), operating margin -83.7%, net loss $18.4M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.

Questions

Did Precision Biosciences beat earnings?

Precision Biosciences (DTIL) reported on Nov 3, 2026 and beat the EPS estimate: −$0.28 against −$0.89 (+68.5%).

When does DTIL report earnings?

The next date is not set yet.

Does Precision Biosciences usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.